Can AI Help Determine If Liver Cancer Will Respond to Standard Treatment?

(MedPage Today) -- VIENNA -- Researchers trained an artificial intelligence (AI) model to determine if a patient with hepatocellular carcinoma (HCC) will respond to standard treatment with atezolizumab (Tecentriq) plus bevacizumab (Avastin)...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news